Avani Medi Aid Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 7.46 M
- Company Age 16 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.39 Cr
- Satisfied Charges ₹ 3.82 Cr
- Revenue Growth 48.69%
- Profit Growth 74.51%
- Ebitda 66.74%
- Net Worth 33.69%
- Total Assets 38.66%
About Avani Medi Aid
Avani Medi Aid Private Limited (AMAPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 November 2008 and has a history of 16 years and three months. Its registered office is in Ranchi, Jharkhand, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.46 M.
The company currently has active open charges totaling ₹5.39 Cr. The company has closed loans amounting to ₹3.82 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shashi Prasad and Neelu Prasad serve as directors at the Company.
Company Details
- Location
Ranchi, Jharkhand, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24236JH2008PTC013380
- Company No.
013380
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jharkhand
Industry
Who are the key members and board of directors at Avani Medi Aid?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shashi Prasad  | Director | 20-Nov-2008 | Current |
| Neelu Prasad | Director | 20-Nov-2008 | Current |
Financial Performance of Avani Medi Aid.
Avani Medi Aid Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.69% increase. The company also saw a substantial improvement in profitability, with a 74.51% increase in profit. The company's net worth Soared by an impressive increase of 33.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avani Medi Aid?
In 2023, Avani Medi Aid had a promoter holding of 56.64% and a public holding of 43.36%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹5.39 Cr
₹3.82 Cr
Charges Breakdown by Lending Institutions
- Others : 5.39 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jul 2021 | Others | ₹4.90 M | Open |
| 19 Dec 2019 | Others | ₹4.90 Cr | Open |
| 05 Mar 2010 | State Bank Of India | ₹3.82 Cr | Satisfied |
How Many Employees Work at Avani Medi Aid?
Unlock and access historical data on people associated with Avani Medi Aid, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avani Medi Aid, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avani Medi Aid's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.